Biogen’s Aduhelm Unites Drug Pricing Advocates
Healthcare purchasers and employers have formed a coalition, EmployersRx, with the goal of convincing House and Senate members to enact [...]
University of Washington Professor Discusses HEOR and RWD Trends
University of Washington’s Anirban Basu discusses his thoughts on the role of real world data (RWD) in health economics and [...]
Biogen Considers Aduhelm Price Cut as Competing Alzheimer’s Drug Approved by FDA
Biogen and its partner Eisai released a statement regarding Alzheimer’s Drug Aduhelm, which is priced at $56,000 per year. The [...]
HealthVerity Webinar Highlights IPGE Platform in Processing RWD
HealthVerity’s Identity, Privacy, Governance and Exchange (IPGE) platform is streamlining the way real world data (RWD) is used to inform [...]
Is Prescription Drug Price Negotiation a Lasting Trend?
One proposed solution to high prescription drug prices is negotiating directly with manufacturers. Legislative changes allowing Medicare to carry out [...]
New ICER Webinar Series on RWD Case Studies; First Webinar on Alzheimer’s Disease Evidence Report
The Institute for Clinical and Economic Review (ICER) will begin a webinar series highlighting findings from recent draft reports and provide [...]
Researchers Identify Biased Algorithms Prevalent Throughout the US Healthcare Industry
University of Chicago researchers found that biased healthcare algorithms are affecting patient care in hospital settings, as well as interactions [...]
Register Today for Upcoming Webinar on RWD in Oncology Drug Development
A webinar on using real world data (RWD) in the context of oncology drug development will feature insight from cancer [...]
CVS Eliminates 72 Hyperinflated Drugs, Saving $1.2 Billion in 2020
CVS has removed 72 high-priced drugs from its formulary. This move has led to $1.2 billion in savings last year [...]
[Cytel Whitepaper] How Can RWE Drive Oncology Drug Development?
Cytel has published a whitepaper detailing how real world evidence (RWE) can be used in cancer drug development, from preclinical [...]
Upcoming IQVIA Webinars on Preparing for Legislative Changes and New Healthcare Trends
IQVIA is hosting a series of webinars to prepare you and your organization for policy changes, including an on-demand webinar [...]
Friday ISPOR Webinar on Value-Based Pricing
ISPOR will host a webinar on the intersection between price and value. Speakers include Omnicom’s Head of Global Health Accounts [...]
Thursday Webinar on Incorporating SDoH RWD to Improve R&D and Support Outreach Efforts
A webinar on understanding and effectively using social determinants of health (SDoH) data will take place on Friday, June 24th [...]
Clinerion Expands RWD Platform, Offers Unique Healthcare Insights Using EHR Data
Clinerion has expanded its Patient Network Explorer tool to include RWD Radar, a service that provides real world data (RWD) [...]
Five Blue Cross Blue Shield Health Insurance Plans to Incorporate Evio to Cut Costs
Five Blue Cross Blue Shield insurance plans will utilize Evio to reduce healthcare costs, including high prescription drug costs. This [...]
New Report Examines Generic Drug Uptake Trends and Impact on Healthcare Costs
ISPOR’s Value in Health journal recently published an article examining generic drug uptake trends in the United States. Researchers assessed [...]
IQVIA RWD Database Provides Detailed Patient Data
IQVIA’S PharMetrics Plus is a comprehensive database that includes health insurance information and extensive patient data from a variety of [...]
AMCP Webinar on Understanding and Effectively Using RWE
The Academy of Managed Care Pharmacy (AMCP) is offering a webinar on real world evidence (RWE). Invited speakers will discuss [...]
Wednesday Webinar on Strategic Healthcare Data Usage, COVID-19 Impact, and Health Equity Strategies for Employers
Register today for a webinar hosted by the Integrated Benefits Institute (IBI) and Purchaser Business Group on Health (PBGH). It [...]
IQVIA Publishes Global Oncology 2021 Report; $164 Billion in Oncology Drug Spending in 2020
The IQVIA Institute has published its Global Oncology Trends 2021 report detailing how the COVID-19 pandemic has impacted oncology research [...]
MAPS 2022 Annual Meeting Encourages Proposals as Deadline Approaches
The Medical Affairs Professional Society (MAPS) welcomes proposals for its 2022 annual meeting, which will take place in New Orleans [...]
Implementation of Magellan Rx Management Oncology Biosimilar Technology Leads to $40 Million in Annualized Savings
Magellan Rx Management announced that its customers have experienced annualized savings exceeding $40 million. The technology solution promotes the use [...]
ISPOR Article Discusses Assigning Value to Novel Therapies
A new article, published in ISPOR’s Value in Health journal, discusses widespread research and development trends. Although exciting new scientific [...]
IQVIA Publishes Report on Pandemic Drug Trends and Future Healthcare Costs Outlook
The IQVIA Institute for Human Data Science has published a report on drug trends noted in the past year, as [...]
New ISPOR Article Compares Net Drug Prices and ICER’s Value-Based Prices
A new article, published in ISPOR’s Value in Health journal, assesses drug prices by comparing net prices to the Institute [...]